PODCAST: SoftBank on foodtech – ‘Scale, scale, scale’

Investment director Angela Du says covid-19 added urgency to the need to build supply chains for alternative proteins and cultured meat.

Subscribe on Apple | Stitcher | Spotify | PodBean | Listen Notes Google Podcasts | Pandora

When SoftBank led a $200 million Series B for indoor farming start-up Plenty in mid-2017, the round was heralded as the largest agtech deal to date. More recently, the venture giant has turned its attention to alternative proteins and cultured meat. In July, the firm drew from the second iteration of its Vision Fund to lead a $350 million Series C for Nature’s Fynd, a start-up developing products from a protein discovered during NASA research into extreme conditions.

In this episode of Spotlight, we hear from Angela Du, one of the executives leading SoftBank’s foodtech investments.